MedPath

TYSABRI 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

TYSABRI 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

106346002

Prescription Type

Uso Hospitalario

Authorization Date

Apr 21, 2021

Dosage Form

SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number106346002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

NATALIZUMABActive
Quantity: 150 mg/ml
Name: NATALIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AG
L04AG03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.